Profile data is unavailable for this security.
About the company
Utah Medical Products, Inc. is engaged in the business of producing medical services. The Company markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit (NICU), the labor and delivery (L&D) department and the women's health center in hospitals, as well as medical devices sold to outpatient clinics and physician's offices. The Company's products include BT-CATH, CVX-RIPE, CVX-RIPE, MUC-X, AROM-CO, DISPOSA-HOOD, DELTRAN PLUS, EPITOME and OptiMicro Electrosurgical Devices, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, and LUMIN. BT-CATH is a uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device used immediately after birth to clear neonatal respiratory passages and reduce exposure to potential infections. AROM-CO is a finger cover with a prong designed to rupture maternal membranes with less patient pain and anxiety.
- Revenue in USD (TTM)50.22m
- Net income in USD16.64m
- Incorporated1978
- Employees169.00
- LocationUtah Medical Products Inc7043 S 300 WestMIDVALE 84047United StatesUSA
- Phone+1 (801) 566-1200
- Fax+1 (801) 566-7305
- Websitehttp://www.utahmed.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inogen Inc | 315.66m | -102.45m | 160.95m | 834.00 | -- | 0.7858 | -- | 0.5099 | -4.42 | -4.42 | 13.62 | 8.78 | 0.8634 | 6.76 | 6.01 | 378,489.20 | -28.02 | -8.23 | -34.53 | -9.53 | 40.14 | 44.54 | -32.46 | -10.31 | 2.56 | -- | 0.00 | -- | -16.32 | -2.49 | -22.30 | -- | 26.34 | -- |
Orchestra Biomed Holdings Inc | 2.76m | -49.12m | 161.71m | 56.00 | -- | 2.38 | -- | 58.59 | -1.49 | -1.49 | 0.0832 | 1.90 | 0.0289 | 0.8815 | 28.31 | 49,285.71 | -51.49 | -- | -61.01 | -- | 93.26 | -- | -1,779.71 | -- | 7.94 | -- | 0.00 | -- | -21.88 | -- | -37.91 | -- | -- | -- |
InfuSystem Holdings Inc | 125.79m | 872.00k | 170.33m | 499.00 | 202.12 | 3.25 | 12.68 | 1.35 | 0.0396 | 0.0396 | 5.86 | 2.47 | 1.24 | 11.17 | 6.85 | 252,074.10 | 0.8621 | 4.60 | 1.01 | 5.69 | 50.17 | 56.43 | 0.6933 | 4.07 | 1.54 | 1.88 | 0.3575 | 0.00 | 14.44 | 13.38 | 4,744.44 | -- | 6.01 | -- |
Akoya Biosciences Inc | 96.63m | -63.32m | 187.23m | 330.00 | -- | 3.48 | -- | 1.94 | -1.48 | -1.48 | 2.18 | 1.09 | 0.5423 | 2.49 | 7.23 | 292,827.30 | -35.53 | -- | -44.59 | -- | 58.27 | -- | -65.53 | -- | 2.94 | -10.94 | 0.5882 | -- | 29.09 | -- | 10.36 | -- | -- | -- |
Semler Scientific Inc | 68.18m | 20.58m | 190.47m | 92.00 | 10.31 | 2.60 | 8.99 | 2.79 | 2.63 | 2.63 | 8.71 | 10.43 | 0.9688 | 15.28 | 13.62 | 741,130.40 | 29.25 | 38.83 | 32.24 | 44.41 | 89.76 | 90.22 | 30.19 | 32.58 | 10.56 | -- | 0.00 | -- | 20.28 | 25.98 | 43.69 | 32.64 | -0.3821 | -- |
Stereotaxis Inc | 26.77m | -22.06m | 210.25m | 122.00 | -- | 12.68 | -- | 7.85 | -0.2737 | -0.2737 | 0.3318 | 0.2708 | 0.5617 | 1.46 | 6.01 | 219,434.40 | -43.46 | -25.02 | -61.11 | -34.12 | 55.51 | 67.57 | -77.37 | -41.90 | 1.88 | -- | 0.00 | -- | -4.89 | -1.82 | -12.33 | -- | 6.63 | -- |
Accuray Inc | 447.48m | -14.55m | 220.15m | 1.02k | -- | 4.62 | -- | 0.492 | -0.1496 | -0.1496 | 4.62 | 0.4806 | 0.9469 | 1.90 | 5.37 | 436,994.20 | -3.08 | -1.45 | -5.28 | -2.48 | 33.97 | 37.86 | -3.25 | -1.62 | 0.8406 | 0.3262 | 0.7857 | -- | 4.12 | 2.03 | -73.56 | -- | 13.92 | -- |
Senseonics Holdings Inc | 22.39m | -60.39m | 228.25m | 132.00 | -- | 6.37 | -- | 10.19 | -0.1023 | -0.1023 | 0.0387 | 0.1385 | 0.1418 | 2.40 | 6.41 | 169,621.20 | -38.24 | -73.65 | -45.21 | -106.97 | 13.81 | -40.41 | -269.73 | -649.86 | 7.03 | -- | 0.3593 | -- | 36.62 | 3.43 | -142.49 | -- | -18.76 | -- |
AngioDynamics, Inc. | 324.01m | -192.37m | 241.53m | 815.00 | -- | 1.11 | -- | 0.7454 | -4.78 | -4.78 | 8.10 | 5.41 | 0.7468 | 2.66 | 6.46 | 397,555.80 | -44.34 | -9.12 | -54.02 | -10.17 | 50.17 | 54.23 | -59.37 | -19.48 | 1.62 | -- | 0.00 | -- | 7.13 | 5.30 | -97.54 | -- | 3.55 | -- |
Utah Medical Products, Inc. | 50.22m | 16.64m | 242.47m | 169.00 | 14.77 | 1.91 | 10.57 | 4.83 | 4.57 | 4.57 | 13.81 | 35.35 | 0.3873 | 2.19 | 11.25 | 297,183.40 | 12.83 | 12.69 | 13.38 | 13.19 | 59.81 | 61.57 | 33.12 | 30.51 | 20.53 | -- | 0.00 | 37.05 | -3.93 | 3.64 | 0.9834 | 1.65 | 9.71 | 1.86 |
Edap Tms SA (ADR) | 64.65m | -22.66m | 263.07m | 307.00 | -- | 4.32 | -- | 4.07 | -0.6126 | -0.6126 | 1.75 | 1.64 | 0.6272 | 2.68 | 3.86 | 210,574.40 | -21.98 | -6.62 | -29.54 | -9.22 | 40.40 | 43.23 | -35.05 | -9.59 | 2.30 | -27.44 | 0.1045 | -- | 9.64 | 9.05 | -622.06 | -- | 32.75 | -- |
Sight Sciences Inc | 81.06m | -55.55m | 279.48m | 214.00 | -- | 2.31 | -- | 3.45 | -1.14 | -1.14 | 1.67 | 2.45 | 0.4269 | 1.70 | 5.51 | 378,761.70 | -29.26 | -38.78 | -31.77 | -42.20 | 85.34 | 80.74 | -68.53 | -105.14 | 12.65 | -10.59 | 0.2201 | -- | 13.63 | 60.84 | 35.59 | -- | 6.77 | -- |
Pulmonx Corp | 68.68m | -60.84m | 291.09m | 279.00 | -- | 2.44 | -- | 4.24 | -1.60 | -1.60 | 1.81 | 3.07 | 0.3698 | 1.14 | 6.61 | 246,147.00 | -32.76 | -26.27 | -36.90 | -28.97 | 73.90 | 71.95 | -88.60 | -93.76 | 5.77 | -- | 0.2394 | -- | 27.98 | 27.98 | -3.26 | -- | 20.62 | -- |
CVRx Inc | 39.30m | -41.20m | 299.06m | 200.00 | -- | 3.93 | -- | 7.61 | -1.99 | -1.99 | 1.89 | 3.64 | 0.3272 | 0.6974 | 6.02 | 196,475.00 | -34.31 | -- | -36.75 | -- | 84.08 | -- | -104.85 | -- | 12.86 | -23.96 | 0.2779 | -- | 74.89 | -- | 0.5528 | -- | -- | -- |
AxoGen Inc | 159.01m | -21.72m | 301.15m | 426.00 | -- | 3.14 | -- | 1.89 | -0.5070 | -0.5070 | 3.71 | 2.22 | 0.8108 | 1.63 | 6.72 | 373,267.60 | -11.07 | -13.92 | -12.85 | -15.84 | 78.46 | 79.74 | -13.66 | -20.28 | 2.14 | -- | 0.3277 | -- | 14.74 | 13.63 | 24.98 | -- | 17.70 | -- |
Holder | Shares | % Held |
---|---|---|
Fidelity Management & Research Co. LLCas of 31 Dec 2023 | 382.07k | 10.65% |
T. Rowe Price Investment Management, Inc.as of 31 Dec 2023 | 269.17k | 7.50% |
Renaissance Technologies LLCas of 31 Dec 2023 | 204.61k | 5.70% |
BlackRock Fund Advisorsas of 31 Dec 2023 | 184.32k | 5.14% |
The Vanguard Group, Inc.as of 31 Dec 2023 | 164.19k | 4.58% |
Dimensional Fund Advisors LPas of 31 Dec 2023 | 163.04k | 4.54% |
Rice, Hall, James & Associates LLCas of 31 Dec 2023 | 105.01k | 2.93% |
Ranger Investment Management LPas of 31 Dec 2023 | 77.59k | 2.16% |
SSgA Funds Management, Inc.as of 31 Dec 2023 | 74.33k | 2.07% |
Geode Capital Management LLCas of 31 Dec 2023 | 72.02k | 2.01% |